Get to know the latest advances in Therapeutics and Prevention in Pediatric Infectious Diseases"

This program arises as a response to an important need in the field of Infectious Diseases. Today, this need responds, among other things, to the emergence of certain diseases that are unknown or have little practice (zika, chikungunya, hemorrhagic fevers, among others), and with others that have fallen into oblivion or are unknown to less experienced pharmacists such as diphtheria, measles, pertussis (whooping cough), or flaccid paralysis associated with poliovirus vaccines.

At the therapeutic level, the emergence of resistance (BLEES, MRSA, carbapenem-resistant enterobacteria, etc.), often caused by the unwise and irrational use of drugs, creates problems for the clinician perform it comes to initial empirical treatment in certain situations. 

On the other hand, parents who refuse vaccines, children from low-income backgrounds, infections in transplant recipients, children with devices and fevers without focus in well-vaccinated children are increasingly common situations that the pharmacist has to deal with.

All this means that, in order to provide the best possible care, the pharmacist must continuously update themselves, even if they are not a specialist, since the percentage of visits or inter-consultations related to infection is very high. If we add to this the increasing amount of information provided by parents, sometimes not always contrasted, professional updating becomes essential to be able to provide adequate information according to the current scientific evidence at all times. 

With this specialization you will have the opportunity to study a program that brings together the most advanced and in-depth knowledge in the field, where a group of highly regarded professors with extensive international experience provides you with the most complete and up-to-date information on the latest advances and techniques developments in Therapeutics and Prevention in Pediatric Infectious Diseases.

Update your knowledge through the Postgraduate certificate in Therapeutics and Prevention in Pediatric Infectious Diseases, in a practical way and adapted to your needs”

This Postgraduate certificate in Therapeutics and Prevention in Pediatric Infectious Diseases contains the most complete and up-to-date scientific program on the market. The most important features include: 

• Development of clinical cases presented by experts in Infectology
• Its graphic, schematic and practical contents are designed to provide scientific and assistance information on those pharmaceutical disciplines that are essential for professional practice
• The latest diagnostic and therapeutic information on how to approach Therapeutics and Prevention in Pediatric Infectious Diseases
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• With a special emphasis on evidence-based medicine and research methodologies in Therapeutics and Prevention in Pediatric Infectious Diseases
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Postgraduate certificate is the best investment you can make when selecting a refresher program, for two reasons: in addition to updating your knowledge developments in Therapeutics and Prevention in Pediatric Infectious Diseases, you will also obtain a qualification endorsed by TECH Global University"

It includes, in its teaching staff, health professionals belonging to the field of Pediatric Infectious Diseases, who bring to this training the experience of their work, in addition to recognized specialists belonging to scientific societies of reference. 

Thanks to its multimedia content developed with the latest educational technology, they will allow the professional a situated and contextual learning, that is to say, a simulated environment that will provide an immersive learning programmed to prepare in real situations. 

This program is designed around Problem-Based Learning, whereby the students must try to solve the different professional practice situations that arise throughout the Postgraduate certificate. For this reason, you will be assisted by an innovative, interactive video system created by renowned and experienced experts in the field of Infectology with extensive teaching experience. 

The Postgraduate certificate includes real clinical cases and exercises to bring the content of the program closer to the clinical practice of a pharmacist"

Make the most of the opportunity to update your knowledge in Pediatric Infectology and improve your patient care"

The structure of the contents has been designed by a team of professionals knowledgeable about the implications of studying in daily Pharmacist practice in Pediatric Infectious Diseases, aware of the relevance of the current the preparation to be able to care for patients with infectious pathology with quality teaching through new educational technologies.

This Postgraduate certificate in Therapeutics and Prevention in Pediatric Infectious Diseases, contains the most complete and up-to-date program on the market”

Module 1. Treatment in Pediatric Infectious Diseases 

1.1. Pharmacokinetics and Pharmacodynamics of Antibacterial Agents in Pediatrics
1.2. Bacterial Resistance and Antibiotherapy

1.2.1. Carbapenem-Resistant Enterobacteriaceae, BLES, MRSA, Vancomycin-Resistant
1.2.2. Resistance to Antifungals

1.3. Choice of Antibiotics in the Different Families

1.3.1. Beta-Lactams
1.3.2. Macrolides
1.3.3. Aminoglycosides
1.3.4. Fluoroquinolones

1.4. Choice Among the Different Families of Antifungals

1.4.1. Azoles
1.4.2. Echinocandins
1.4.3. Polyenes

1.5. Resurrection of Old Therapeutic Agents
1.6. New Antibiotics or Families

1.6.1. Ceftobiprole, Ceftaroline, Doripenem, Dalbavancin, Talavicina, Teixobactin, Ceftolozane-Tazobactam, Ceftazidime-Avibactam, Lugdunin, Oritavancin, Iclaprim, Ramoplanin, Fidaxomicin, Fidaxomicin

1.7. New Tuberculostatics
1.8. Antibiotherapy in Obese Pediatric Patients
1.9. New Requirements for the Rational and Judicious Choice of Suitable Treatment

1.9.1. Antibiotic Policy in Hospitals and Primary Care Optimization Program

1.10. Role of Agriculture and Animal Husbandry in Antibiotic Resistance
1.11. Use of Antivirals

1.11.1. In Immunocompetent Patients
1.11.2. Use of Antivirals in Immunocompromised Patients

1.12. Essential Antiparasitic Drugs in Pediatrics
1.13. Update on Allergy to Anti-Infectives Alternatives
1.14. Monitoring of Anti-Infectives
1.15. Update on the Duration of Antibiotic Treatments

Module 2. Preventive Measures 

2.1. Control and Response to Hospital Outbreaks of Infection

2.1.1. Common Microorganisms
2.1.2. Current Multidrug-Resistant Microorganisms (Including Decontamination in the MRSA Patient)

2.2. Hospital Organization and Control of Today's Multidrug-Resistant Microorganisms
2.3. Current Indications for Isolation in Hospital Pediatrics
2.4. Current Vaccines

2.4.1. Prematurity
2.4.2. Immunodeficient Child
2.4.3. Child Undergoing Immunosuppressive Treatments
2.4.4. Splenectomized Patients
2.4.5. Transplant Recipients
2.4.6. HIV

2.5. Update on Vaccination of Children in Special Situations
2.6. Current Indications for Antibiotic Prophylaxis
2.7. Indications for Prophylaxis

2.7.1. In case of Accidental Puncture
2.7.2. Indications for Sexual Abuse Prophylaxis

2.8. Post-Exposure Performance

2.8.1. Chickenpox
2.8.2. Measles
2.8.3. In Hepatitis B
2.8.4. In Hepatitis A
2.8.5. Tuberculosis
2.8.6. Tetanus
2.8.7. Rabies

2.9. Current Status of Perioperative Prophylaxis of the Surgical Patient
2.10. Update on Antibiotic Prophylaxis in Transplant Children and Patients Treated for Atypical Hemolytic Uremic Syndrome

The teaching materials of this program, elaborated by these specialists, have contents that are completely applicable to your professional experiences"